ZYMEWORKS INC. Other Non-Current Liabilities
ZYMEWORKS INC. (ZYME) had Other Non-Current Liabilities of $278.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Noncurrent $278.00K.
- 2026-03-31: Other Liabilities, Noncurrent $278.00K.
- 2025-12-31: Other Liabilities, Noncurrent $278.00K.
- 2025-09-30: Other Liabilities, Noncurrent $278.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $278.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $278.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $278.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $278.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $828.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $856.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $923.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $929.00K 10-Q · filed 2024-10-31 |
| 2024-06-30 | $1.23M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $1.59M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $1.70M 10-K · filed 2025-03-05 |
| 2023-09-30 | $1.86M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $3.60M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $3.60M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $3.10M 10-K · filed 2024-03-06 |
| 2022-09-30 | $2.93M 10-Q · filed 2022-11-08 |
| 2021-12-31 | $2.75M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |